A Superstable Homogeneous Lipiodol-Nanoformulation to Overcome the Dilemma of Interventional Embolization Chemotherapy
Open Access
- 21 June 2022
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 952194
Abstract
A Superstable Homogeneous Lipiodol-Nanoformulation to Overcome the Dilemma of Interventional Embolization ChemotherapyKeywords
Funding Information
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China (81925019)
This publication has 19 references indexed in Scilit:
- Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapyJournal of Controlled Release, 2021
- Targeting Strategies for Enhancing Paclitaxel Specificity in ChemotherapyFrontiers in Cell and Developmental Biology, 2021
- Hepatocellular carcinomaNature Reviews Disease Primers, 2021
- Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolizationScience Bulletin, 2020
- A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatmentJournal of Controlled Release, 2020
- The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicineChinese Chemical Letters, 2020
- A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinomaHPB, 2020
- Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 UpdateCancers, 2020
- Epidemiology and surveillance for hepatocellular carcinoma: New trendsJournal of Hepatology, 2020
- Computer‐aided diagnosis for the classification of focal liver lesions by use of contrast‐enhanced ultrasonographyMedical Physics, 2008